Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Depreciation and Depletion (2020 - 2025)

Tarsus Pharmaceuticals has reported Depreciation and Depletion over the past 6 years, most recently at $202000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $202000.0 for Q4 2025, up 5.21% from a year ago — trailing twelve months through Dec 2025 was $822000.0 (up 18.79% YoY), and the annual figure for FY2025 was $855000.0, up 24.82%.
  • Depreciation and Depletion for Q4 2025 was $202000.0 at Tarsus Pharmaceuticals, up from $200000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for TARS hit a ceiling of $247000.0 in Q4 2023 and a floor of $64000.0 in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $192000.0 (2024), compared with a mean of $155473.7.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 635.29% in 2021 and later crashed 50.0% in 2024.
  • Tarsus Pharmaceuticals' Depreciation and Depletion stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then surged by 147.0% to $247000.0 in 2023, then decreased by 22.27% to $192000.0 in 2024, then rose by 5.21% to $202000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $202000.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.